Literature DB >> 221844

The effect of naloxone on cerebellar cGMP content. A possible GABA-antagonistic action?

S W Gumulka, V Dinnendahl, P S Schönhöfer.   

Abstract

Naloxone in high doses (60--240 mg/kg i.p.) produced a dose-dependent increase in cerebellar cGMP content of mice. The rise in cGMP content reached its maximum within 5 min and was of short duration. Short-lasting episodes of clonic seizures were noted after 240 mg/kg naloxone. Low doses of naloxone (5--10 mg/kg) had no effect on cerebellar cGMP content, but markedly potentiated the increase in cGMP induced by isoniazid. On the other hand, naloxone (5 mg/kg) partially antagonized the fall in cGMP elicited by diazepam, but had only a slight effect on the action of pentobarbital (30 mg/kg i.p.). These results support the assumption proposed by other authors that naloxone exerts GABA antagonistic effects aside from the potent opiate receptor antagonistic activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221844     DOI: 10.1007/bf00498987

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  The use of naloxone in the treatment of diazepam poisoning.

Authors:  E F Bell
Journal:  J Pediatr       Date:  1975-11       Impact factor: 4.406

Review 2.  New concepts on the mechanism of action of benzodiazepines.

Authors:  E Costa; A Guidotti; C C Mao; A Suria
Journal:  Life Sci       Date:  1975-07-15       Impact factor: 5.037

3.  Pentobarbital selectively enhances GABA-mediated post-synaptic inhibition in tissue cultured mouse spinal neurons.

Authors:  B R Ransom; J L Barker
Journal:  Brain Res       Date:  1976-09-24       Impact factor: 3.252

Review 4.  Evidence for involvement of GABA in the action of benzodiazepines: studies on rat cerebellum.

Authors:  E Costa; A Guidotti; C C Mao
Journal:  Adv Biochem Psychopharmacol       Date:  1975

5.  A rapid and simple procedure for the determination of guanosine 3',5'-monophosphate by use of the protein-binding method.

Authors:  V Dinnendahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  The effect of diazepam on spinal cord activities: possible sites and mechanisms of action.

Authors:  P Polc; H Möhler; W Haefely
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

7.  Stress-induced alterations of cyclic nucleotide levels in brain: effects of centrally acting drugs.

Authors:  V Dinnendahl; S W Gumulka
Journal:  Psychopharmacology (Berl)       Date:  1977-05-09       Impact factor: 4.530

8.  Effect of desmethyldiazepam and chlordesmethyldiazepam on 3',5'-cyclic guanosine monophosphate levels in rat cerebellum.

Authors:  S Govoni; P Fresia; P F Spano; M Trabucchi
Journal:  Psychopharmacology (Berl)       Date:  1976-11-24       Impact factor: 4.530

9.  Effects of stimulatory and depressant drugs on cyclic guanosine 3',5'-monophosphate and adenosine 3',5'-monophosphate levels in mouse brain.

Authors:  F A Opmeer; S W Gumulka; V Dinnedahl; P S Schönhöfer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

10.  Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies.

Authors:  R Dingledine; L L Iversen; E Breuker
Journal:  Eur J Pharmacol       Date:  1978-01-01       Impact factor: 4.432

View more
  2 in total

1.  Effects of activators and blockers of the ligand-operated Cl- channels on the chloride sensitivity of microsomal Mg(2+)-ATPase of bream (Abramis brama L.) brain.

Authors:  S A Menzikov; O V Menzikova
Journal:  Dokl Biochem Biophys       Date:  2001 May-Jun       Impact factor: 0.788

2.  Naloxone-induced electrographic seizures in the primate.

Authors:  E W Snyder; D E Shearer; E C Beck; R E Dustmann
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.